Company Overview

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
17,258M
2025 FY
Net Income
1,410M
2025 FY
Shares Outstanding
1,145M
2025 FY
EPS
1.23USD
2025 FY
Company Information
SIC Code
2834
CIK Code
818686
Exchange
NYSE
Location
IL